Bone loss after liver transplants can be prevented
A new study found that the drug used to treat osteoporosis, when used in combination with calcium and vitamin D, can prevent the additional bone loss that commonly occurs after liver transplants. The treatment also helped stabilize bone loss in patients who already had osteoporosis, and helped improve their bone mineral density (BMD).
The results of this study appear in the August 2005 issue of Liver Transplantation, the official journal of the American Association for the Study of Liver Diseases (AASLD) and the International Liver Transplantation Society (ILTS). The journal is published on behalf of the societies by John Wiley & Sons, Inc. and is available online via Wiley InterScience at http://www.interscience.wiley.com/journal/livertransplantion.
Osteoporosis occurs in a large number of patients with end stage liver disease, and is often worsened by the immunosuppressive drugs normally given to prevent rejection following liver transplants. To date, however, studies have not been conducted and no guidelines exist for the treatment of bone loss following liver transplant.
In order to determine the effectiveness of medication in preventing bone loss after liver transplants, researchers led by Gunda Millonig of the Department of Gastroenterology and Hepatology at Innsbruck Medical University in Innsbruck, Austria, assessed osteoporosis in 136 pre-liver transplant patients between January 1999 and December 2003. All patients on the waiting list were given 1000 mg of calcium and 400 IE of vitamin D daily, and bisphosphonate (alendronate, the drug used to treat osteoporosis) was given following liver transplant to those patients who had either osteopenia (a decrease in bone density that can lead to osteoporosis) or osteoporosis before transplant. Patients whose BMD decreased following the transplant were also given bisphosphonate.
"The striking result of this study was that alendronate combined with calcium and vitamin D almost completely prevented further bone loss in the first 4 months after LT [liver transplant]," the authors state. "This is a significant improvement compared to the natural course of bone loss within the first few months after LT as reported in numerous publications." In addition, patients with osteopenia and osteoporosis, which accounted for 72 percent of the patients in the study, remained stable on the alendronate therapy for the first four months after transplant and showed significantly improved BMD over the next three years, although for the most part their BMD did not ever reach normal levels.
"Our study suggests that oral alendronate therapy immediately after LT in patients with osteoporosis/osteopenia is effective in preventing bone loss subsequent to LT," the authors conclude. They note, however, that while the results are promising, further randomized studies are needed.
Amy Molnar | EurekAlert!
The most recent press releases about innovation >>>
Die letzten 5 Focus-News des innovations-reports im Überblick:
Computer scientists use wave packet theory to develop realistic, detailed water wave simulations in real time. Their results will be presented at this year’s SIGGRAPH conference.
Think about the last time you were at a lake, river, or the ocean. Remember the ripples of the water, the waves crashing against the rocks, the wake following...
An international team of scientists has proposed a new multi-disciplinary approach in which an array of new technologies will allow us to map biodiversity and the risks that wildlife is facing at the scale of whole landscapes. The findings are published in Nature Ecology and Evolution. This international research is led by the Kunming Institute of Zoology from China, University of East Anglia, University of Leicester and the Leibniz Institute for Zoo and Wildlife Research.
Using a combination of satellite and ground data, the team proposes that it is now possible to map biodiversity with an accuracy that has not been previously...
Heatwaves in the Arctic, longer periods of vegetation in Europe, severe floods in West Africa – starting in 2021, scientists want to explore the emissions of the greenhouse gas methane with the German-French satellite MERLIN. This is made possible by a new robust laser system of the Fraunhofer Institute for Laser Technology ILT in Aachen, which achieves unprecedented measurement accuracy.
Methane is primarily the result of the decomposition of organic matter. The gas has a 25 times greater warming potential than carbon dioxide, but is not as...
Hydrogen is regarded as the energy source of the future: It is produced with solar power and can be used to generate heat and electricity in fuel cells. Empa researchers have now succeeded in decoding the movement of hydrogen ions in crystals – a key step towards more efficient energy conversion in the hydrogen industry of tomorrow.
As charge carriers, electrons and ions play the leading role in electrochemical energy storage devices and converters such as batteries and fuel cells. Proton...
Scientists from the Excellence Cluster Universe at the Ludwig-Maximilians-Universität Munich have establised "Cosmowebportal", a unique data centre for cosmological simulations located at the Leibniz Supercomputing Centre (LRZ) of the Bavarian Academy of Sciences. The complete results of a series of large hydrodynamical cosmological simulations are available, with data volumes typically exceeding several hundred terabytes. Scientists worldwide can interactively explore these complex simulations via a web interface and directly access the results.
With current telescopes, scientists can observe our Universe’s galaxies and galaxy clusters and their distribution along an invisible cosmic web. From the...